National AAPS Presentation: Transdermal Films for the Delivery of HIV Therapeutics

October 1, 2011

In 2010, Dr. Ham was awarded a Phase I SBIR grant to develop transdermal films for the delivery of HIV therapeutics. ImQuest Biosciences developed a transdermal patch which releases more than 96 percent of the HIV medication over the course of seven days. “As we enter the fourth decade of HIV/AIDS, this new delivery method will hopefully reduce the numerous pills most HIV patients have to take daily,” said lead researcher Anthony Ham. “Taking medicines regularly reduces symptoms in HIV patients and extends lives. The transdermal patch offers an easier option for patients to comply with their medication regimes as compared to current treatments.” With an estimated 15 million people living with HIV in developing countries and only 5.3 million people with access to treatment, this offers a more affordable and accessible way to address this unmet medical need. The research was presented at the National AAPS meeting in Washington, D.C.

Return to Press Releases